{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:12:30Z","timestamp":1790446350495,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,3,5]]},"DOI":"10.1038\/s41416-025-03317-6","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T10:10:08Z","timestamp":1766311808000},"page":"707-720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of mitotically active polyploid giant cancer cells on chemoresistance through interaction with cancer-associated fibroblasts"],"prefix":"10.1038","volume":"134","author":[{"given":"Go","family":"Itoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma","family":"Fukushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurara","family":"Takagane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kanetaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Iemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6086-2858","authenticated-orcid":false,"given":"Kozo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8776-9004","authenticated-orcid":false,"given":"Akiteru","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4823-9737","authenticated-orcid":false,"given":"Masamitsu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"key":"3317_CR1","doi-asserted-by":"publisher","unstructured":"Song Y, Zhao Y, Deng Z, Zhao R, Huang Q. Stress-induced polyploid giant cancer cells: unique way of formation and non-negligible characteristics. Front Oncol. 2021. https:\/\/doi.org\/10.3389\/fonc.2021.724781.","DOI":"10.3389\/fonc.2021.724781"},{"key":"3317_CR2","doi-asserted-by":"publisher","unstructured":"Molony P, Werner R, Martin C, Callanan D, Sheahan P, Heffron C, et al. Tumour cell anaplasia and multinucleation as prognosticators in oropharyngeal squamous cell carcinoma. Head Neck Pathol. 2020. https:\/\/doi.org\/10.1007\/s12105-019-01081-7.","DOI":"10.1007\/s12105-019-01081-7"},{"key":"3317_CR3","doi-asserted-by":"publisher","unstructured":"Liu HT, Xia T, You YW, Zhang QC, Ni HS, Liu YF, et al. Characteristics and clinical significance of polyploid giant cancer cells in laryngeal carcinoma. Laryngoscope Investig Otolaryngol. 2021. https:\/\/doi.org\/10.1002\/lio2.667.","DOI":"10.1002\/lio2.667"},{"key":"3317_CR4","doi-asserted-by":"publisher","unstructured":"Ogden A, Rida PC, Knudsen BS, Kucuk O, Aneja R Docetaxel-induced polyploidization may underlie chemoresistance and disease relapse. Cancer Lett. 2015. https:\/\/doi.org\/10.1016\/j.canlet.2015.06.025.","DOI":"10.1016\/j.canlet.2015.06.025"},{"key":"3317_CR5","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41416-023-02408-6","volume":"129","author":"T Matsuura","year":"2023","unstructured":"Matsuura T, Ueda Y, Harada Y, Hayashi K, Horisaka K, Yano Y, et al. Histological diagnosis of polyploidy discriminates an aggressive subset of hepatocellular carcinomas with poor prognosis. Br J Cancer. 2023;129:1251\u201360. https:\/\/doi.org\/10.1038\/s41416-023-02408-6.","journal-title":"Br J Cancer"},{"key":"3317_CR6","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1080\/26895293.2020.1806117","volume":"13","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Yang J, Maimaitiyimin R, Ma M, Zhang H, Wang R. Radiation-induced mitotic catastrophe is associated with down-regulated ribosomal biosynthesis and mitosis genes. All Life. 2020;13:474\u201385. https:\/\/doi.org\/10.1080\/26895293.2020.1806117.","journal-title":"All Life"},{"key":"3317_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/onc.2013.96","volume":"33","author":"S Zhang","year":"2014","unstructured":"Zhang S, Mercado-Uribe I, Xing Z, Sun B, Kuang J, Liu J. Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Oncogene. 2014;33:116\u201328. https:\/\/doi.org\/10.1038\/onc.2013.96.","journal-title":"Oncogene"},{"key":"3317_CR8","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1038\/s41388-021-01715-7","volume":"40","author":"Z Nehme","year":"2021","unstructured":"Nehme Z, Pasquereau S, Haidar Ahmad S, Coaquette A, Molimard C, Monnien F, et al. Polyploid giant cancer cells, stemness and epithelial-mesenchymal plasticity elicited by human cytomegalovirus. Oncogene. 2021;40:3030\u201346. https:\/\/doi.org\/10.1038\/s41388-021-01715-7.","journal-title":"Oncogene"},{"key":"3317_CR9","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.cellbi.2008.04.021","volume":"32","author":"PE Puig","year":"2008","unstructured":"Puig PE, Guilly MN, Bouchot A, Droin N, Cathelin D, Bouyer F, et al. Tumor cells can escape DNA-damaging cisplatin through DNA endoreduplication and reversible polyploidy. Cell Biol Int. 2008;32:1031\u201343. https:\/\/doi.org\/10.1016\/j.cellbi.2008.04.021.","journal-title":"Cell Biol Int"},{"key":"3317_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.semcancer.2021.04.005","volume":"81","author":"J Zhang","year":"2022","unstructured":"Zhang J, Qiao Q, Xu H, Zhou R, Liu X. Human cell polyploidization: the good and the evil. Semin Cancer Biol. 2022;81:54\u201363. https:\/\/doi.org\/10.1016\/j.semcancer.2021.04.005.","journal-title":"Semin Cancer Biol"},{"key":"3317_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/biolre\/ioab102","volume":"105","author":"JS Richards","year":"2021","unstructured":"Richards JS, Candelaria NR, Lanz RB. Polyploid giant cancer cells and ovarian cancer: new insights into mitotic regulators and polyploidy. Biol Reprod. 2021;105:305\u201316. https:\/\/doi.org\/10.1093\/biolre\/ioab102.","journal-title":"Biol Reprod"},{"key":"3317_CR12","doi-asserted-by":"publisher","first-page":"1410637","DOI":"10.3389\/fcell.2024.1410637","volume":"12","author":"P Liu","year":"2024","unstructured":"Liu P, Wang L, Yu H. Polyploid giant cancer cells: origin, possible pathways of formation, characteristics, and mechanisms of regulation. Front Cell Dev Biol. 2024;12:1410637 https:\/\/doi.org\/10.3389\/fcell.2024.1410637.","journal-title":"Front Cell Dev Biol"},{"key":"3317_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5306\/wjco.v11.i3.121","volume":"11","author":"I Shabo","year":"2020","unstructured":"Shabo I, Svanvik J, Lindstr\u00f6m A, Lechertier T, Trabulo S, Hulit J, et al. Roles of cell fusion, hybridization and polyploid cell formation in cancer metastasis. World J Clin Oncol. 2020;11:121\u201335. https:\/\/doi.org\/10.5306\/wjco.v11.i3.121.","journal-title":"World J Clin Oncol"},{"key":"3317_CR14","doi-asserted-by":"publisher","unstructured":"White-Gilbertson S, Voelkel-Johnson C. Giants and monsters: Unexpected characters in the story of cancer recurrence. Adv Cancer Res. 2022;148:201\u2013232. https:\/\/doi.org\/10.1016\/bs.acr.2020.03.001.","DOI":"10.1016\/bs.acr.2020.03.001"},{"key":"3317_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1006\/cbir.2000.0557","volume":"24","author":"TM Illidge","year":"2000","unstructured":"Illidge TM, Cragg MS, Fringes B, Olive P, Erenpreisa JA. Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damage. Cell Biol Int. 2000;24:621\u201333. https:\/\/doi.org\/10.1006\/cbir.2000.0557.","journal-title":"Cell Biol Int"},{"key":"3317_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.18632\/genesandcancer.102","volume":"7","author":"S Zhang","year":"2016","unstructured":"Zhang S, Mercado-Uribe I, Sood A, Bast RC, Liu J. Coevolution of neoplastic epithelial cells and multilineage stroma via polyploid giant cells during immortalization and transformation of mullerian epithelial cells. Genes Cancer. 2016;7:60\u201372. https:\/\/doi.org\/10.18632\/genesandcancer.102.","journal-title":"Genes Cancer"},{"key":"3317_CR17","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/ijc.28319","volume":"134","author":"S Zhang","year":"2014","unstructured":"Zhang S, Mercado-Uribe I, Liu J. Tumor stroma and differentiated cancer cells can be originated directly from polyploid giant cancer cells induced by paclitaxel. Int J Cancer. 2014;134:508\u201318. https:\/\/doi.org\/10.1002\/ijc.28319.","journal-title":"Int J Cancer"},{"key":"3317_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.7150\/jca.17012","volume":"8","author":"D Zhang","year":"2017","unstructured":"Zhang D, Yang X, Yang Z, Fei F, Li S, Qu J, et al. Daughter cells and erythroid cells budding from PGCCs and their clinicopathological significances in colorectal cancer. J Cancer. 2017;8:469\u201378. https:\/\/doi.org\/10.7150\/jca.17012.","journal-title":"J Cancer"},{"key":"3317_CR19","doi-asserted-by":"publisher","first-page":"80120","DOI":"10.1371\/journal.pone.0080120","volume":"8","author":"S Zhang","year":"2013","unstructured":"Zhang S, Mercado-Uribe I, Hanash S, Liu J. iTRAQ-based proteomic analysis of polyploid giant cancer cells and budding progeny cells reveals several distinct pathways for ovarian cancer development. PLoS ONE. 2013;8:80120 https:\/\/doi.org\/10.1371\/journal.pone.0080120.","journal-title":"PLoS ONE"},{"key":"3317_CR20","doi-asserted-by":"publisher","unstructured":"Linares J, Mar\u00edn-Jim\u00e9nez JA, Badia-Ramentol J, Calon A. Determinants and functions of CAFs secretome during cancer progression and therapy. Front Cell Dev Biol. 2021;8. https:\/\/doi.org\/10.3389\/fcell.2020.621070.","DOI":"10.3389\/fcell.2020.621070"},{"key":"3317_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01125-0","volume":"21","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Li T, Yuan Y, Zhu Y. What is new in cancer-associated fibroblast biomarkers?. Cell Commun Signal. 2023;21:96. https:\/\/doi.org\/10.1186\/s12964-023-01125-0.","journal-title":"Cell Commun Signal"},{"key":"3317_CR22","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.3390\/cancers15092614","volume":"15","author":"A Brichkina","year":"2023","unstructured":"Brichkina A, Polo P, Sharma SD, Visestamkul N, Lauth M. A quick guide to CAF subtypes in pancreatic cancer. Cancers. 2023;15:2614 https:\/\/doi.org\/10.3390\/cancers15092614.","journal-title":"Cancers"},{"key":"3317_CR23","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.trecan.2019.09.010","volume":"5","author":"BA Pereira","year":"2019","unstructured":"Pereira BA, Vennin C, Papanicolaou M, Chambers CR, Herrmann D, Morton JP, et al. CAF Subpopulations: a new reservoir of stromal targets in pancreatic cancer. Trends Cancer. 2019;5:724\u201341. https:\/\/doi.org\/10.1016\/j.trecan.2019.09.010.","journal-title":"Trends Cancer"},{"key":"3317_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cytogfr.2022.09.001","volume":"68","author":"T Luong","year":"2022","unstructured":"Luong T, Golivi Y, Nagaraju GP, El-Rayes BF. Fibroblast heterogeneity in pancreatic ductal adenocarcinoma: perspectives in immunotherapy. Cytokine Growth Factor Rev. 2022;68:107\u201315. https:\/\/doi.org\/10.1016\/j.cytogfr.2022.09.001.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3317_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"G Biffi","year":"2019","unstructured":"Biffi G, Oni TE, Spielman B, Hao Y, Elyada E, Park Y, et al. IL1-Induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov. 2019;9:282\u2013301. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0710.","journal-title":"Cancer Discov"},{"key":"3317_CR26","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1002\/1878-0261.13053","volume":"15","author":"L Fang","year":"2021","unstructured":"Fang L, Che Y, Zhang C, Huang J, Lei Y, Lu Z, et al. LAMC1 upregulation via TGF\u03b2 induces inflammatory cancer-associated fibroblasts in esophageal squamous cell carcinoma via NF-\u03baB-CXCL1-STAT3. Mol Oncol. 2021;15:3125\u201346. https:\/\/doi.org\/10.1002\/1878-0261.13053.","journal-title":"Mol Oncol"},{"key":"3317_CR27","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 2019;9:1102\u201323. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0094.","journal-title":"Cancer Discov"},{"key":"3317_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22164-5","volume":"8","author":"G Itoh","year":"2018","unstructured":"Itoh G, Ikeda M, Iemura K, Amin MA, Kuriyama S, Tanaka M, et al. Lateral attachment of kinetochores to microtubules is enriched in prometaphase rosette and facilitates chromosome alignment and bi-orientation establishment. Sci Rep. 2018;8:3888. https:\/\/doi.org\/10.1038\/s41598-018-22164-5.","journal-title":"Sci Rep"},{"key":"3317_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36036-5","volume":"8","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Aung KM, Uhlin BE, Wai SN. Reversible senescence of human colon cancer cells after blockage of mitosis\/cytokinesis caused by the CNF1 cyclomodulin from Escherichia coli. Sci Rep. 2018;8:17780. https:\/\/doi.org\/10.1038\/s41598-018-36036-5.","journal-title":"Sci Rep"},{"key":"3317_CR30","doi-asserted-by":"publisher","first-page":"13666","DOI":"10.18632\/oncotarget.24446","volume":"9","author":"AJ Legrand","year":"2018","unstructured":"Legrand AJ, Poletto M, Pankova D, Clementi E, Moore J, Castro-Giner F, et al. Persistent DNA strand breaks induce a CAF-like phenotype in normal fibroblasts. Oncotarget. 2018;9:13666\u201381. https:\/\/doi.org\/10.18632\/oncotarget.24446.","journal-title":"Oncotarget"},{"key":"3317_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00109-015-1266-2","volume":"93","author":"A Laurenzana","year":"2015","unstructured":"Laurenzana A, Biagioni A, Bianchini F, Peppicelli S, Chill\u00e0 A, Margheri F, et al. Inhibition of uPAR-TGF\u03b2 crosstalk blocks MSC-dependent EMT in melanoma cells. J Mol Med. 2015;93:783\u201394. https:\/\/doi.org\/10.1007\/s00109-015-1266-2.","journal-title":"J Mol Med"},{"key":"3317_CR32","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/dvdy.24554","volume":"247","author":"JF Santibanez","year":"2018","unstructured":"Santibanez JF, Obradovi\u0107 H, Kukolj T, Krsti\u0107 J. Transforming growth factor-\u03b2, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition. Dev Dyn. 2018;247:382\u201395. https:\/\/doi.org\/10.1002\/dvdy.24554.","journal-title":"Dev Dyn"},{"key":"3317_CR33","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1038\/s41388-018-0272-6","volume":"37","author":"A Parekh","year":"2018","unstructured":"Parekh A, Das S, Parida S, Das CK, Dutta D, Mallick SK, et al. Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo. Oncogene. 2018;37:4546\u201361. https:\/\/doi.org\/10.1038\/s41388-018-0272-6.","journal-title":"Oncogene"},{"key":"3317_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pbiomolbio.2021.05.002","volume":"165","author":"MD Kuczler","year":"2021","unstructured":"Kuczler MD, Olseen AM, Pienta KJ, Amend SR. ROS-induced cell cycle arrest as a mechanism of resistance in polyaneuploid cancer cells (PACCs). Prog Biophys Mol Biol. 2021;165:3\u20137. https:\/\/doi.org\/10.1016\/j.pbiomolbio.2021.05.002.","journal-title":"Prog Biophys Mol Biol"},{"key":"3317_CR35","doi-asserted-by":"publisher","first-page":"100881","DOI":"10.1016\/j.drup.2022.100881","volume":"65","author":"ER Smith","year":"2022","unstructured":"Smith ER, Wang JQ, Yang DH, Xu XX. Paclitaxel resistance related to nuclear envelope structural sturdiness. Drug Resist Updat. 2022;65:100881 https:\/\/doi.org\/10.1016\/j.drup.2022.100881.","journal-title":"Drug Resist Updat"},{"key":"3317_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.freeradbiomed.2016.12.031","volume":"103","author":"GF Wang","year":"2017","unstructured":"Wang GF, Dong Q, Bai Y, Yuan J, Xu Q, Cao C, et al. Oxidative stress induces mitotic arrest by inhibiting Aurora A-involved mitotic spindle formation. Free Radic Biol Med. 2017;103:177\u201387. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.12.031.","journal-title":"Free Radic Biol Med"},{"key":"3317_CR37","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.neo.2015.11.008","volume":"17","author":"G Mosieniak","year":"2015","unstructured":"Mosieniak G, Sliwinska MA, Alster O, Strzeszewska A, Sunderland P, Piechota M, et al. Polyploidy formation in doxorubicin-treated cancer cells can favor escape from senescence. Neoplasia. 2015;17:882\u201393. https:\/\/doi.org\/10.1016\/j.neo.2015.11.008.","journal-title":"Neoplasia"},{"key":"3317_CR38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1269\/jrr.10186","volume":"52","author":"P Li","year":"2011","unstructured":"Li P, Zhou L, Dai Z, Jin X, Liu X, Matsumoto Y, et al. High LET radiation enhances nocodazole Induced cell death in HeLa cells through mitotic catastrophe and apoptosis. J Radiat Res. 2011;52:481\u20139. https:\/\/doi.org\/10.1269\/jrr.10186.","journal-title":"J Radiat Res"},{"key":"3317_CR39","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/sj.onc.1204126","volume":"20","author":"H Tsuiki","year":"2001","unstructured":"Tsuiki H, Nitta M, Tada M, Inagaki M, Ushio Y, Saya H. Mechanism of hyperploid cell formation induced by microtubule inhibiting drug in glioma cell lines. Oncogene. 2001;20:420\u20139. https:\/\/doi.org\/10.1038\/sj.onc.1204126.","journal-title":"Oncogene"},{"key":"3317_CR40","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s13402-016-0282-8","volume":"39","author":"LA Flores-L\u00f3pez","year":"2016","unstructured":"Flores-L\u00f3pez LA, Mart\u00ednez-Hern\u00e1ndez MG, Viedma-Rodr\u00edguez R, D\u00edaz-Flores M, Baiza-Gutman LA. High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells. Cell Oncol. 2016;39:365\u201378. https:\/\/doi.org\/10.1007\/s13402-016-0282-8.","journal-title":"Cell Oncol"},{"key":"3317_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1756-9966-28-73","volume":"28","author":"KH Lee","year":"2009","unstructured":"Lee KH, Kim SW, Kim JR. Reactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells. J Exp Clin Cancer Res. 2009;28:73 https:\/\/doi.org\/10.1186\/1756-9966-28-73.","journal-title":"J Exp Clin Cancer Res"},{"key":"3317_CR42","doi-asserted-by":"publisher","unstructured":"Mahmood N, Mihalcioiu C, Rabbani SA. Multifaceted role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): diagnostic, prognostic, and therapeutic applications. Front Oncol. 2018;8. https:\/\/doi.org\/10.3389\/fonc.2018.00024.","DOI":"10.3389\/fonc.2018.00024"},{"key":"3317_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/srep21903","volume":"6","author":"A Moirangthem","year":"2016","unstructured":"Moirangthem A, Bondhopadhyay B, Mukherjee M, Bandyopadhyay A, Mukherjee N, Konar K, et al. Simultaneous knockdown of uPA and MMP9 can reduce breast cancer progression by increasing cell-cell adhesion and modulating EMT genes. Sci Rep. 2016;6:21903. https:\/\/doi.org\/10.1038\/srep21903.","journal-title":"Sci Rep"},{"key":"3317_CR44","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.cellsig.2012.05.011","volume":"24","author":"BM Eastman","year":"2012","unstructured":"Eastman BM, Jo M, Webb DL, Takimoto S, Gonias SL. A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen. Cell Signal. 2012;24:1847\u201355. https:\/\/doi.org\/10.1016\/j.cellsig.2012.05.011.","journal-title":"Cell Signal"},{"key":"3317_CR45","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1038\/sj.onc.1205342","volume":"21","author":"JA Aguirre Ghiso","year":"2002","unstructured":"Aguirre Ghiso JA. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene. 2002;21:2513\u201324. https:\/\/doi.org\/10.1038\/sj.onc.1205342.","journal-title":"Oncogene"},{"key":"3317_CR46","doi-asserted-by":"publisher","first-page":"7026","DOI":"10.7150\/jca.62281","volume":"12","author":"T Lv","year":"2021","unstructured":"Lv T, Zhao Y, Jiang X, Yuan H, Wang H, Cui X, et al. uPAR: an essential factor for tumor development. J Cancer. 2021;12:7026\u20137040. https:\/\/doi.org\/10.7150\/jca.62281.","journal-title":"J Cancer"},{"key":"3317_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03329-3","volume":"20","author":"BT Zhai","year":"2022","unstructured":"Zhai BT, Tian H, Sun J, Zou JB, Zhang XF, Cheng JX, et al. Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer. J Transl Med. 2022;20:135. https:\/\/doi.org\/10.1186\/s12967-022-03329-3.","journal-title":"J Transl Med"},{"key":"3317_CR48","doi-asserted-by":"publisher","unstructured":"Chen WC, Wu CC, Liu YP, Zhuo GY, Wang YK, Chen YH, et al. Elafin as a prognostic marker in esophageal squamous cell carcinoma: a pilot study using three-dimensional imaging and genomic profiling. Cancers. 2023;15. https:\/\/doi.org\/10.3390\/cancers15153825.","DOI":"10.3390\/cancers15153825"},{"key":"3317_CR49","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1136\/gut.2003.026831","volume":"53","author":"VM D\u00edaz","year":"2004","unstructured":"D\u00edaz VM, Hurtado M, Thomson TM, Revent\u00f3s J, Paciucci R. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Gut. 2004;53:993\u20131000. https:\/\/doi.org\/10.1136\/gut.2003.026831.","journal-title":"Gut"},{"key":"3317_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00689-4","volume":"12","author":"PC Sch\u00f6pe","year":"2024","unstructured":"Sch\u00f6pe PC, Torke S, Kobelt D, Kort\u00fcm B, Treese C, Dumbani M, et al. MACC1 revisited- an in-depth review of a master of metastasis. Biomark Res. 2024;12:146. https:\/\/doi.org\/10.1186\/s40364-024-00689-4.","journal-title":"Biomark Res"},{"key":"3317_CR51","doi-asserted-by":"publisher","first-page":"1336696","DOI":"10.3389\/fonc.2024.1336696","volume":"14","author":"H Zheng","year":"2024","unstructured":"Zheng H, Wu X, Guo L, Liu J. MyD88 signaling pathways: role in breast cancer. Front Oncol. 2024;14:1336696 https:\/\/doi.org\/10.3389\/fonc.2024.1336696.","journal-title":"Front Oncol"},{"key":"3317_CR52","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s00432-022-04004-2","volume":"148","author":"H Li","year":"2022","unstructured":"Li H, Yu Z, Wang H, Wang N, Sun X, Yang S, et al. Role of ANO1 in tumors and tumor immunity. J Cancer Res Clin Oncol. 2022;148:2045\u201368. https:\/\/doi.org\/10.1007\/s00432-022-04004-2.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3317_CR53","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.2147\/OTT.S190934","volume":"ume 12","author":"H Sun","year":"2019","unstructured":"Sun H, Liu K, Huang J, Sun Q, Shao C, Luo J, et al. FAM111B, a direct target of p53, promotes the malignant process of lung adenocarcinoma. Onco Targets Ther. 2019;ume 12:2829\u201342. https:\/\/doi.org\/10.2147\/OTT.S190934.","journal-title":"Onco Targets Ther"},{"key":"3317_CR54","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.3390\/cancers12082269","volume":"12","author":"A Batool","year":"2020","unstructured":"Batool A, Liu H, Liu YX, Chen SR. CD83, a novel MAPK signaling pathway interactor, determines ovarian cancer cell fate. Cancers. 2020;12:2269 https:\/\/doi.org\/10.3390\/cancers12082269.","journal-title":"Cancers"},{"key":"3317_CR55","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1002\/ijc.24624","volume":"125","author":"N Oue","year":"2009","unstructured":"Oue N, Sentani K, Noguchi T, Ohara S, Sakamoto N, Hayashi T, et al. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int J Cancer. 2009;125:2383\u201392. https:\/\/doi.org\/10.1002\/ijc.24624.","journal-title":"Int J Cancer"},{"key":"3317_CR56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2021.12.011","volume":"527","author":"M Li","year":"2022","unstructured":"Li M, Jin S, Zhang Z, Ma H, Yang X. Interleukin-6 facilitates tumor progression by inducing ferroptosis resistance in head and neck squamous cell carcinoma. Cancer Lett. 2022;527:28\u201340. https:\/\/doi.org\/10.1016\/j.canlet.2021.12.011.","journal-title":"Cancer Lett"},{"key":"3317_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-024-02422-5","volume":"41","author":"AH Mohamed","year":"2024","unstructured":"Mohamed AH, Ahmed AT, Al Abdulmonem W, Bokov DO, Shafie A, Al-Hetty HRAK, et al. Interleukin-6 serves as a critical factor in various cancer progression and therapy. Med Oncol. 2024;41:182. https:\/\/doi.org\/10.1007\/s12032-024-02422-5.","journal-title":"Med Oncol"},{"key":"3317_CR58","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/BST20220838","volume":"51","author":"B Beernaert","year":"2023","unstructured":"Beernaert B, Parkes EE. cGAS-STING signalling in cancer: striking a balance with chromosomal instability. Biochem Soc Trans. 2023;51:539\u201355.","journal-title":"Biochem Soc Trans"},{"key":"3317_CR59","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13039-019-0429-1","volume":"12","author":"AE Tijhuis","year":"2019","unstructured":"Tijhuis AE, Johnson SC, McClelland SE. The emerging links between chromosomal instability (CIN), metastasis, inflammation and tumour immunity. Mol Cytogenet. 2019;12:17.","journal-title":"Mol Cytogenet"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03317-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03317-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03317-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:21:06Z","timestamp":1770974466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03317-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,3,5]]}},"alternative-id":["3317"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03317-6","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,21]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki principles. This study was approved by the Akita University Ethics Committee (approval number a-1-3175, Akita, Japan).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We have obtained consent from the relevant parties for the publication of the research results.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}